Krempa David sold ETON
May 26, 2026 · Form 4 insider transaction
Krempa David sold 37,524 shares of Eton Pharmaceuticals, Inc. at $31.49 per share, a transaction worth $1.18M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
37,524
Price
$31.49
Total value
$1.18M
InsiderKrempa David
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 26, 2026
Filing dateMay 27, 2026
Shares owned after25,249
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.; The shares were sold in multiple trades at prices ranging from $31.27 to $32.16. The price reported above reflects the weighted average sales price.